Synthesis and biological evaluation of 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimdin-5(6H)-ones as functionally selective ligands of the benzodiazepine receptor site on the GABAA receptor

被引:33
作者
Albaugh, PA
Marshall, L
Gregory, J
White, G
Hutchison, A
Ross, PC
Gallagher, DW
Tallman, JF
Crago, M
Cassella, JV
机构
[1] Neurogen Corp, Dept Chem, Branford, CT 06405 USA
[2] Neurogen Corp, Dept Pharmacol, Branford, CT 06405 USA
[3] Neurogen Corp, Dept Electrophysiol, Branford, CT 06405 USA
[4] Neurogen Corp, Dept Biol Mol, Branford, CT 06405 USA
[5] Neurogen Corp, Dept Behav Biol, Branford, CT 06405 USA
关键词
D O I
10.1021/jm0202019
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Benzodiazepines are allosteric modulators of the GABA(A) receptor. The traditionally prescribed benzodiazepines are nonselective and suffer from numerous side effects. Upon the identification of receptor subtypes, we set out to discover selective agents with the anticipation that these agents would have superior therapeutic potential. Herein, we describe the synthesis and biological evaluation of substituted 7,8,9,10-tetrahydroimidazo[1,2-c]pyrido[3,4-e]pyrimidin-5(6H)-ones and disclose that these compounds exhibit functional selectivity at the benzodiazepine receptor of GABAA receptor subtypes. The alpha(2)/alpha(3)-selective partial agonist 42 exhibited potent in vivo activity.
引用
收藏
页码:5043 / 5051
页数:9
相关论文
共 21 条
  • [1] SYNTHETIC AND COMPUTER-ASSISTED ANALYSIS OF THE PHARMACOPHORE FOR AGONISTS AT BENZODIAZEPINE RECEPTORS
    DIAZARAUZO, H
    KOEHLER, KF
    HAGEN, TJ
    COOK, JM
    [J]. LIFE SCIENCES, 1991, 49 (03) : 207 - 216
  • [2] SYNTHESIS AND EVALUATION OF A SERIES OF ARYL[E]FUSED PYRAZOLO[4,3-C]PYRIDINES WITH POTENTIAL ANXIOLYTIC ACTIVITY
    FORBES, IT
    JOHNSON, CN
    JONES, GE
    LOUDON, J
    NICHOLASS, JM
    THOMPSON, M
    UPTON, N
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) : 2640 - 2645
  • [3] ANXIOLYTIC PROPERTIES OF CERTAIN ANNELATED [1,2,4]TRIAZOLO[1,5-C]PYRIMIDIN-5(6H)-ONES
    FRANCIS, JE
    BENNETT, DA
    HYUN, JL
    ROVINSKI, SL
    AMRICK, CL
    LOO, PS
    MURPHY, D
    NEALE, RF
    WILSON, DE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (09) : 2899 - 2906
  • [4] SYNTHESIS AND BENZODIAZEPINE BINDING-ACTIVITY OF A SERIES OF NOVEL [1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5(6H)-ONES
    FRANCIS, JE
    CASH, WD
    BARBAZ, BS
    BERNARD, PS
    LOVELL, RA
    MAZZENGA, GC
    FRIEDMANN, RC
    HYUN, JL
    BRAUNWALDER, AF
    LOO, PS
    BENNETT, DA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (01) : 281 - 290
  • [5] Residual effects of zaleplon and zolpidem following middle of the night administration five hours to one hour before awakening
    Hindmarch, I
    Patat, A
    Stanley, N
    Paty, I
    Rigney, U
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (02) : 159 - 167
  • [6] RESOLUTION OF 2 BIOCHEMICALLY AND PHARMACOLOGICALLY DISTINCT BENZODIAZEPINE RECEPTORS
    KLEPNER, CA
    LIPPA, AS
    BENSON, DI
    SANO, MC
    BEER, B
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (04) : 457 - 462
  • [7] Knight AR, 1998, RECEPTOR CHANNEL, V6, P1
  • [8] Effects of alcohol, zolpidem, and some other sedatives and hypnotics on human performance and memory
    Mattila, MJ
    Vanakoski, J
    Kalska, H
    Seppälä, T
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 59 (04) : 917 - 923
  • [9] Triazolam and zolpidem: effects on human memory and attentional processes
    Mintzer, MZ
    Griffiths, RR
    [J]. PSYCHOPHARMACOLOGY, 1999, 144 (01) : 8 - 19
  • [10] Pharmacodynamic profile of zaleplon, a new non-benzodiazepine hypnotic agent
    Patat, A
    Paty, I
    Hindmarch, I
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (05) : 369 - 392